Medtronic 2024 Investor Handout: FY25 Growth Strategy and Earnings Outlook

Medtronic presents its strategic momentum across multiple business fronts, highlighting mid-single digit organic revenue growth and new product innovation in cardiac, neuromodulation, spine, and diabetes markets. The company outlines its transformation progress, improved operational performance, and commitment to restoring earnings power with expected operating margin expansion and mid-single digit adjusted EPS growth in FY25.